NCT05804279View on ClinicalTrials.gov

Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 28, 2022

Primary Completion Date

February 21, 2023

Study Completion Date

March 14, 2023

Conditions

Healthy

Interventions

DRUG

BPDO-1603

donepezil/mematine

Trial Locations (1)

06121

Hyundaipharm, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Hyundai Pharm

INDUSTRY